Radiation Treatment, ATM, BRCA1/2, and CHEK2*1100delC Pathogenic Variants and Risk of Contralateral Breast Cancer.
Reiner AS, Robson ME, Mellemkjær L, Tischkowitz M, John EM, Lynch CF, Brooks JD, Boice JD, Knight JA, Teraoka SN, Liang X, Woods M, Shen R, Shore RE, Stram DO, Thomas DC, Malone KE, Bernstein L, Riaz N, Woodward W, Powell S, Goldgar D, Concannon P; WECARE Study Collaborative Group; Bernstein JL.
Reiner AS, et al. Among authors: brooks jd.
J Natl Cancer Inst. 2020 Dec 14;112(12):1275-1279. doi: 10.1093/jnci/djaa031.
J Natl Cancer Inst. 2020.
PMID: 32119081
Free PMC article.